We are live on
!
Find out more
CCM
Cullen Capital Management Portfolio holdings
AUM
$9.75B
1-Year Est. Return
21.81%
This Fund
S&P 500
This Quarter
Est. Return
+1.8%
1 Year Est. Return
+21.81%
3 Year Est. Return
+48.84%
5 Year Est. Return
+62.4%
10 Year Est. Return
+166.06%
AUM
$3.3B
AUM Growth
–
Cap. Flow
+$3.33B
Cap. Flow
% of AUM
101.21%
Top 10 Holdings %
Top 10 Hldgs %
31.03%
Holding
184
New
184
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$112M |
| 2 |
ConocoPhillips
COP
|
+$106M |
| 3 |
RTN
Raytheon Company
RTN
|
+$104M |
| 4 |
Merck
MRK
|
+$104M |
| 5 |
Vodafone
VOD
|
+$103M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 13.05% |
| 2 | Healthcare | 11.96% |
| 3 | Industrials | 11.51% |
| 4 | Financials | 10.74% |
| 5 | Consumer Staples | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UN
26
DELISTED
Unilever NV New York Registry Shares
UN
| $75.9M | 2.3% |
+1,931,100
| New | +$79.5M |
|
27
AstraZeneca
AZN
$269B
| $71.6M | 2.17% |
+1,513,500
| New | +$77.1M |
|
|
RDS.B
28
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $67.1M | 2.03% |
+1,011,790
| New | +$69.1M |
|
29
Healthpeak Properties
DOC
$15.5B
| $66.1M | 2.01% |
+1,596,723
| New | +$72.8M |
|
30
Diageo
DEO
$49.6B
| $59.1M | 1.8% |
+514,530
| New | +$62.2M |
|
31
Genuine Parts
GPC
$17.9B
| $57.5M | 1.74% |
+736,150
| New | +$57.1M |
|
|
DD
32
DELISTED
Du Pont De Nemours E I
DD
| $56.4M | 1.71% |
+1,131,870
| New | +$57.1M |
|
33
Dominion Energy
D
$62B
| $49.8M | 1.51% |
+876,650
| New | +$51.4M |
|
|
KRFT
34
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $44.6M | 1.35% |
+798,023
| New | +$42.8M |
|
|
PTR
35
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $36.7M | 1.11% |
+331,665
| New | +$40M |
|
|
SJR
36
DELISTED
Shaw Communications Inc.
SJR
| $20.9M | 0.64% |
+870,750
| New | +$19.9M |
|
37
Equinor
EQNR
$97.3B
| $19.2M | 0.58% |
+926,350
| New | +$21.3M |
|
38
Novartis
NVS
$302B
| $10.8M | 0.33% |
+170,960
| New | +$11.1M |
|
39
Manulife Financial
MFC
$73B
| $9.61M | 0.29% |
+599,600
| New | +$9.09M |
|
|
ABB
40
DELISTED
ABB Ltd
ABB
| $8.68M | 0.26% |
+400,550
| New | +$8.87M |
|
41
TotalEnergies
TTE
$193B
| $8.04M | 0.24% |
+165,070
| New | +$8.15M |
|
42
British American Tobacco
BTI
$136B
| $7.45M | 0.23% |
+144,640
| New | +$7.96M |
|
43
CEMIG Preferred Shares
CIG
$6.06B
| $2.54M | 0.08% |
+726,269
| New | +$2.94M |
|
44
KBR
KBR
$4.56B
| $865K | 0.03% |
+26,630
| New | +$849K |
|
45
Halliburton
HAL
$26.1B
| $862K | 0.03% |
+20,650
| New | +$863K |
|
46
Becton Dickinson
BDX
$46.4B
| $805K | 0.02% |
+8,354
| New | +$797K |
|
47
Cardinal Health
CAH
$53.7B
| $800K | 0.02% |
+16,950
| New | +$774K |
|
48
Occidental Petroleum
OXY
$55.7B
| $794K | 0.02% |
+9,290
| New | +$785K |
|
49
Wells Fargo
WFC
$254B
| $792K | 0.02% |
+19,200
| New | +$748K |
|
50
Walt Disney
DIS
$171B
| $789K | 0.02% |
+12,500
| New | +$790K |
|
Similar funds
FCM
URS
MPI
HL
DCP
CIM
MF
HI
Cullen Capital Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Cullen Capital Management, which disclosed 184 positions worth $3.3B. Its ten largest holdings account for 31% of the portfolio.
Its largest position is Eli Lilly: 2,049,500 shares worth $101M.
By sector, the portfolio is most concentrated in Energy at 13% of assets, followed by Healthcare and Industrials.
- Cullen Capital Management's largest Q2 2013 buy was Eli Lilly: 2,049,500 shares worth $101M.
- Cullen Capital Management's ten largest holdings make up 31% of its $3.3B portfolio in Q2 2013.
- Cullen Capital Management disclosed 184 positions in Q2 2013, its first 13F filing on record.
Based on Cullen Capital Management's 13F filing for Q2 2013, filed 14 Aug 2013.